TORONTO and GLIL YAM, Israel, May 6, 2025 — IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the “Company“, “IMCannabis“, or “IMC“), a prominent medical cannabis company operating in Israel and Germany, will announce its operational and financial performance for the first quarter of 2025, which concluded on March 31, 2025, on Thursday, May 15, 2025, before the opening of the market.

 

 

The company will conduct a Zoom web conference on the same day at 9:00am ET to discuss the results and hold a Q&A session for investors. Investors can register by clicking . Registration will provide all pertinent details.

A recording of the call will be posted on our website at within 24 hours for those unable to attend the live event.

Zoom call link:

About IM Cannabis Corp.

IMC (Nasdaq: IMCC) (CSE: IMCC) is a global cannabis company delivering premium cannabis products to medical patients in both Israel and Germany, two significant medical cannabis markets. The company’s primary objective is to achieve consistent and profitable growth within its key markets of Israel and Germany. IMC utilizes a transnational ecosystem, enhanced by data-driven insights and a globally sourced supply chain. Committed to responsible growth and adherence to stringent regulatory standards, IMC aims to strengthen its market presence and brand recognition to establish itself as a leading global provider of high-quality cannabis.

In Israel, the IMC ecosystem is facilitated through its commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, using extensive data and patient insights. The company also manages medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel, ensuring the safe delivery and quality control of IMC products throughout the entire value chain. Within Germany, the IMC ecosystem operates through Adjupharm GmbH, which distributes cannabis to pharmacies for medical cannabis patients.

Company Contact:

Anna Taranko, Director Investor & Public Relations
IM Cannabis Corp.
+49 157 80554338

Oren Shuster, CEO
IM Cannabis Corp.
+972-77-3603504

Logo:

 

SOURCE IM Cannabis Corp.